Skip to Main Content

  • Obtained dismissal for a client in a federal FCA case alleging a $100 million federal government contracting fraud scheme.
  • Despite target letters from DOJ alleging violations of the FCA, successfully defended an executive vice president of a national post-acute care company, with no claims filed.
  • Representing the owner of a real estate development and management company in defending against an investigation by DOJ involving $300 million in alleged FCA damages.
  • Successfully settled, on a no-fault basis for nuisance value, a $100 million-plus, bet-the-company DOJ civil FCA case involving parallel criminal charges against a healthcare management, diagnostic and hospice care services provider, including achieving a favorable appellate decision quashing the government’s search, seizure and retention of privileged materials.
  • Representing an alternative energy company in defense of state FCA allegations relating to a failed several-hundred-million-dollar energy project.
  • Representing a national provider of career training schools in response to an FCA investigation by DOJ with potential penalties of up to $180 million relating to tuition reimbursement allegations under the GI Bill.
  • Representing a former top executive at a military contractor in a $40 million criminal investigation in the midst of a potential civil FCA lawsuit.
  • Representing a global staffing company to perform an internal investigation and respond to a civil investigative demand from DOJ related to potential FCA violations.
  • Successfully settled, for a minimal amount, a bet-the-business civil FCA case filed by an individual relator asserting over $100 million in federal FCA, Stark Law and Anti-Kickback Statute violations related to billing for medical tests and alleged improper relationships with physicians.
  • Representing a former top executive of a marketing company in connection with a DOJ investigation into the payment of alleged kickbacks and the submission of false claims for cardio and cancer genetic testing, purportedly exceeding $25 million.
  • Representing a client in an ongoing companion civil and criminal False Claims Act investigation being conducted by the U.S. Attorney’s Office for the Southern District of Ohio.
  • Representing a multi-state provider of physical therapy services in connection with a DOJ FCA investigation and related civil investigative demand.
  • Counsel to numerous physician practice groups in defense of federal FCA investigations, government enforcement actions and internal investigations.
  • Representation of a large orthopedic practice group in defense of a DOJ FCA case involving allegations of AKS/Stark violations.
  • Counsel to a specialty pharmacy company in a federal FCA investigation.
  • Representation of a variety of healthcare clients in the defense of civil FCA actions and whistleblower lawsuits.
  • Conducted an FCA investigation pertaining to sale of medical devices under a Federal Supply Schedule contract.
  • Represented the Chief Compliance Officer of a publicly traded pharmaceutical company in a criminal investigation involving FCA and Iranian sanctions issues.
  • Represented physicians in a DOJ civil FCA investigation initiated as a result of a qui tam complaint.
  • Conducted an internal investigation for a multinational corporation and also defended against a government investigation into alleged violations of immigration law and the FCA.
  • Conducted an internal investigation for a Fortune 500 company into a foreign subsidiary involving allegations of employee misconduct and potential FCA violations.
  • Represented an officer of a pharmaceutical company in connection with a DOJ investigation into marketing practices and potential violations of the Anti-Kickback Statute and the FCA.
  • Conducted an internal investigation associated with a DOJ investigation of a large physician practice group relating to an FCA case involving allegations of overutilization of and billing for ancillary testing.

Featured Insights